CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- 4 Grant or award Director acquired 125,000 shares (grant or award)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- UPLOAD Other SEC-generated Letter
- 4 Grant or award Director acquired 67,416 shares (grant or award)
- 4 Grant or award Director acquired 67,416 shares (grant or award)
- 4 Grant or award Director acquired 67,416 shares (grant or award)
- S-1 Offering Registration Statement
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 4 Grant or award Director acquired 61,539 shares (grant or award)
- 4 Grant or award Director acquired 3,699 shares (grant or award)
- 4 Grant or award Director acquired 44,379 shares (grant or award)
- 4 Grant or award Director acquired 47,042 shares (grant or award)
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
Page 4 of 29 · 563 filings